CPSI 2018 Proxy Statement

41 Management (UK) Ltd., BlackRock Asset Management Canada Limited, BlackRock Investment Management (Australia) Limited, BlackRock (Netherlands) B.V., BlackRock Fund Advisors, BlackRock Asset Management Ireland Limited, BlackRock Institutional Trust Company, N.A., BlackRock Financial Management, Inc., BlackRock Japan Co., Ltd., BlackRock Asset Management Schweiz AG and BlackRock Investment Management, LLC, acquired the shares being reported and (c) Blackrock, Inc. has sole voting power with respect to 1,434,474 shares and sole dispositive power with respect to all 1,458,080 shares. (5) The address of The Vanguard Group, Inc. is 100 Vanguard Blvd., Malvern, Pennsylvania 19355. This information is based solely upon our review of an amended Schedule 13G filed by The Vanguard Group, Inc. (“Vanguard Group”) with the SEC on February 9, 2018, reporting beneficial ownership as of December 31, 2017. The Schedule 13G/A reports that, of the 1,223,930 shares reported as beneficially owned, Vanguard Group has sole voting power with respect to 16,882 shares, shared voting power with respect to 849 shares, sole dispositive power with respect to 1,206,750 shares and shared dispositive power with respect to 17,180 shares. The Schedule 13G/A reports that Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of Vanguard Group, is the beneficial owner of 16,331 shares as a result of its serving as investment manager of collective trust accounts. The Schedule 13G/A also reports that Vanguard Investments Australia, Ltd., a wholly-owned subsidiary of Vanguard Group, is the beneficial owner of 1,400 shares as a result of its serving as investment manager of Australian investment offerings. (6) The address of Brown Brothers Harriman & Co. is 140 Broadway, New York, New York 10005. This information is based solely upon our review of an amended Schedule 13G filed by Brown Brothers Harriman & Co. (“Brown Brothers”) with the SEC on February 13, 2017, reporting beneficial ownership as of February 13, 2017. The Schedule 13G/A reports that, of the 1,201,050 shares reported as beneficially owned, Brown Brothers has sole voting and dispositive power with respect to all 1,201,050 shares. Brown Brothers has not disclosed an amended Schedule 13G since such date. (7) Includes 1,017,110 shares held by Gilead Capital LP, Gilead Capital GP LLC and Jeffrey A. Strong (collectively, “Gilead Capital”) with shared voting and dispositive power. The address of Gilead Capital is 157 Columbus Avenue, Suite 403, New York, New York 10023. This information is based solely upon our review of an amended Schedule 13G filed by Gilead Capital with the SEC on January 23, 2018, reporting beneficial ownership as of December 31, 2017. (8) The address of River Road Asset Management, LLC is 462 South 4 th Street, Suite 2000, Louisville, Kentucky 40202. This information is based solely upon our review of an amended Schedule 13G filed by River Road Asset Management, LLC (“River Road”) with the SEC on February 9, 2018, reporting beneficial ownership as of December 31, 2017. The Schedule 13G/A reports that, of the 799,345 shares reported as beneficially owned, River Road has sole voting power with respect to 754,022 shares and sole dispositive power with respect to all 799,345 shares. (9) The address of Quantum Capital Management, LLC is 105 East Mill Road, Northfield, New Jersey 08225. This information is based solely upon our review of a Schedule 13G filed by Quantum Capital Management, LLC (“Quantum”) with the SEC on February 9, 2018, reporting beneficial ownership as of December 31, 2017. The Schedule 13G reports that, of the 708,795 shares reported as beneficially owned, Quantum has sole voting and dispositive power with respect to all 708,795 shares. (10) Mr. Douglas shares voting and investment power for 100 shares with his wife. Includes a total of 600 shares held in custodial accounts for the benefit of his three children. Also includes 47,166 shares of unvested restricted stock granted to Mr. Douglas under the Company’s 2014 Incentive Plan comprised of (i) 5,009 shares granted on March 14, 2016, (ii) 17,391 shares granted on May 11, 2017, (iii) 14,170 shares granted on February 19, 2018 (pursuant to an earned performance share award) and (iv) 10,596 shares granted on March 6, 2018. (11) Includes 56,400 shares owned by a trust for the benefit of Mr. Dye and his children. Also includes 47,166 shares of unvested restricted stock granted to Mr. Dye under the Company’s 2014 Incentive Plan comprised of (i) 5,009 shares granted on March 14, 2016, (ii) 17,391 shares granted on May 11, 2017, (iii) 14,170 shares granted on February 19, 2018 (pursuant to an earned performance share award) and (iv) 10,596 shares granted on March 6, 2018. (12) Includes 4,499 shares of unvested restricted stock granted to Dr. Benjamin under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors comprised of (i) 1,188 shares granted on November 9, 2017 and (ii) 3,311 shares granted on March 6, 2018. (13) Mr. Huffman shares voting and investment power for 2,000 shares with his wife. Includes 7,659 shares of unvested restricted stock granted to Mr. Huffman under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors comprised of (i) 4,348 shares granted on May 11, 2017 and (ii) 3,311 shares granted on March 6, 2018. (14) Includes 7,659 shares of unvested restricted stock granted to Mr. Johnson under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors comprised of (i) 4,348 shares granted on May 11, 2017 and (ii) 3,311 shares granted on March 6, 2018. (15) Mr. Mulherin shares voting and investment power for 1,400 shares with his wife. Includes 372 shares held in a custodial account for the benefit of his daughter. Also includes 7,659 shares of unvested restricted stock granted to Mr. Mulherin under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors comprised of (i) 4,348 shares granted on May 11, 2017 and (ii) 3,311 shares granted on March 6, 2018. (16) Includes 7,659 shares of unvested restricted stock granted to Mr. Outlaw under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors comprised of (i) 4,348 shares granted on May 11, 2017 and (ii) 3,311 shares granted on March 6, 2018. (17) Includes 4,348 shares of unvested restricted stock granted to Mr. Seifert under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors on May 11, 2017. (18) Includes 4,499 shares of unvested restricted stock granted to Mr. Tobin under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors comprised of (i) 1,188 shares granted on November 9, 2017 and (ii) 3,311 shares granted on March 6, 2018. (19) Includes 4,499 shares of unvested restricted stock granted to Ms. Warren under the Company’s 2012 Restricted Stock Plan for Non-Employee Directors comprised of (i) 1,188 shares granted on November 9, 2017 and (ii) 3,311 shares granted on March 6, 2018. (20) Includes 36,699 shares of unvested restricted stock granted to Mr. Chambless under the Company’s 2014 Incentive Plan comprised of (i) 3,757 shares granted on March 14, 2016, (ii) 13,043 shares granted on May 11, 2017, (iii) 10,627 shares granted on February 19, 2018 (pursuant to an earned performance share award) and (iv) 9,272 shares granted on March 6, 2018. . (21) Includes 47,166 shares of unvested restricted stock granted to Mr. Fowler under the Company’s 2014 Incentive Plan comprised of (i) 5,009 shares granted on March 14, 2016, (ii) 17,391 shares granted on May 11, 2017, (iii) 14,170 shares granted on February 19, 2018 (pursuant to an earned performance share award) and (iv) 10,596 shares granted on March 6, 2018. (22) Includes 28,390 shares of unvested restricted stock granted to Mr. Rosser under the Company’s 2014 Incentive Plan comprised of (i) 2,817 shares granted on March 14, 2016, (ii) 9,783 shares granted on May 11, 2017, (iii) 9,167 shares granted on February 19, 2018 (pursuant to an earned performance share award) and (iv) 6,623 shares granted on March 6, 2018. (23) Includes shares of unvested restricted stock as described in footnotes (10)-(22).